These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30211221)

  • 1. Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.
    Mauceri R; Panzarella V; Maniscalco L; Bedogni A; Licata ME; Albanese A; Toia F; Cumbo EMG; Mazzola G; Di Fede O; Campisi G
    Biomed Res Int; 2018; 2018():3982540. PubMed ID: 30211221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma.
    Curi MM; Cossolin GS; Koga DH; Zardetto C; Christianini S; Feher O; Cardoso CL; dos Santos MO
    J Oral Maxillofac Surg; 2011 Sep; 69(9):2465-72. PubMed ID: 21763050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.
    Vescovi P; Manfredi M; Merigo E; Guidotti R; Meleti M; Pedrazzi G; Fornaini C; Bonanini M; Ferri T; Nammour S
    Photomed Laser Surg; 2012 Jan; 30(1):5-13. PubMed ID: 22054203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
    Atalay B; Yalcin S; Emes Y; Aktas I; Aybar B; Issever H; Mandel NM; Cetin O; Oncu B
    Lasers Med Sci; 2011 Nov; 26(6):815-23. PubMed ID: 21809068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
    Gonzálvez-García M; Rodríguez-Lozano FJ; Villanueva V; Segarra-Fenoll D; Rodríguez-González MA; Oñate-Sánchez R; Blanquer M; Moraleda JM
    J Craniofac Surg; 2013 May; 24(3):e226-8. PubMed ID: 23714970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; Georgiev-Hristov T; Ruiz Bravo-Burguillos E; Abarrategi A; Burgueño M; García-Arranz M
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1161-8. PubMed ID: 26027865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases.
    Mozzati M; Gallesio G; Arata V; Pol R; Scoletta M
    Oral Oncol; 2012 May; 48(5):469-74. PubMed ID: 22265335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P; Nammour S
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III.
    Bodem JP; Schaal C; Kargus S; Saure D; Mertens C; Engel M; Hoffmann J; Freudlsperger C
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Apr; 121(4):367-72. PubMed ID: 26795450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
    Gil IG; Ponte BM; Mateo ST; García JJ
    J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    O'Ryan FS; Lo JC
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bisphosphonate-related osteonecrosis using platelet-rich plasma: microtomographic, microscopic, and immunohistochemical analyses.
    Cardoso CL; Curra C; Curi MM; Matsumoto MA; Argentino CD; Franzolin SOB; Constantino D; Barbosa DN; Ferreira Júnior O
    Braz Oral Res; 2019 Jul; 33():e050. PubMed ID: 31269114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT).
    Vescovi P; Manfredi M; Merigo E; Meleti M; Fornaini C; Rocca JP; Nammour S
    Lasers Med Sci; 2010 Jan; 25(1):101-13. PubMed ID: 19543768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.
    Weber JB; Camilotti RS; Ponte ME
    Lasers Med Sci; 2016 Aug; 31(6):1261-72. PubMed ID: 27025860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients.
    Nisi M; La Ferla F; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    Br J Oral Maxillofac Surg; 2016 Oct; 54(8):930-935. PubMed ID: 27418080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw.
    Janovska Z; Mottl R; Slezak R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):313-7. PubMed ID: 24108250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.